TCI GENE Inc. (TPEX:6879)
Taiwan
· Delayed Price · Currency is TWD 37.00
-0.20 (-0.54%)
Apr 29, 2026, 11:36 AM CST
TCI GENE Market Cap
TCI GENE has a market cap or net worth of 984.26 million as of April 29, 2026. Its market cap has decreased by -27.91% in one year.
Market Cap
984.26M
Enterprise Value
183.50M
Revenue
273.61M
Ranking
n/a
PE Ratio
24.47
Stock Price
37.00
Market Cap Chart
Since January 25, 2022, TCI GENE's market cap has decreased from 2.14B to 984.26M, a decrease of -53.90%. That is a compound annual growth rate of -16.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 984.26M | 4.79% |
| Dec 31, 2025 | 939.28M | -34.50% |
| Dec 26, 2024 | 1.43B | -35.55% |
| Dec 29, 2023 | 2.23B | -28.42% |
| Dec 30, 2022 | 3.11B | 45.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lukas Biomedical | 1.01B |
| Taiwan Advance Bio-Pharmaceutical | 1.07B |
| Level Biotechnology | 1.09B |
| NatureWise Biotech & Medicals | 897.75M |
| GeneReach Biotechnology | 1.15B |
| BiOptic | 1.20B |
| Holy Stone Healthcare | 1.20B |
| MegaPro Biomedical | 799.30M |